Institutionelles- und Fonds-Eigentümerschaft - Käufer
Zu den wichtigsten Inhabern, die neue Positionen in Crescent Biopharma, Inc. eröffnet haben, gehören Vanguard Capital Management Llc, Exome Asset Management LLC, Jennison Associates Llc, Silverarc Capital Management, Llc, Hudson Bay Capital Management LP, Vanguard Fiduciary Trust Co, Lighthouse Investment Partners, LLC, Brevan Howard Capital Management LP, Algert Global Llc, Verdad Advisers, LP, Cannon Global Investment Management, LLC, Vanguard Global Advisers, LLC, Allworth Financial LP, Fortitude Family Office, LLC, und Caitong International Asset Management Co., Ltd .
Diese Seite zeigt Veränderungen in der Eigentümerstruktur, indem sie Institutionen, Fonds und Großaktionäre auflistet, die im letzten Berichtszeitraum ihre Bestände erhöht oder neue Positionen eröffnet haben. Grüne Zeilen weisen auf neue Positionen hin. Klicken Sie auf das Link-Symbol, um den vollständigen Transaktionsverlauf anzuzeigen.
Upgradezum Freischalten von Premium-Daten.
| Datei Datum | Quelle | Anleger | Typ | Durchschnittlicher Preis (Est) |
Aktien | Δ Aktien (%) |
Gemeldeter Wert ($1000) |
Δ Wert (%) |
Port Alloc (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13F | Susquehanna International Group, Llp | 213.635 | 274,48 | 3.924 | 480,47 | ||||
| 2026-05-15 | 13F | State Street Corp | 39.067 | 49,01 | 718 | 131,29 | ||||
| 2026-05-14 | 13F | Allworth Financial LP | 161 | 3 | ||||||
| 2026-05-14 | 13F | Silverarc Capital Management, Llc | 130.500 | 2.397 | ||||||
| 2026-05-12 | 13F | Bnp Paribas Arbitrage, Sa | 15.694 | 337,77 | 288 | 585,71 | ||||
| 2026-05-05 | 13F | UBS Group AG | 82.706 | 1.060,79 | 1.519 | 1.708,33 | ||||
| 2026-05-15 | 13F | OMERS ADMINISTRATION Corp | 17.800 | 53,45 | 327 | 137,96 | ||||
| 2026-05-11 | 13F | Citigroup Inc | 20.169 | 3.137,40 | 371 | 5.185,71 | ||||
| 2026-05-15 | 13F | Geode Capital Management, Llc | 104.221 | 14,43 | 1.916 | 77,15 | ||||
| 2026-04-15 | 13F | Fortitude Family Office, LLC | 40 | 1 | ||||||
| 2026-04-21 | 13F | Cannon Global Investment Management, LLC | 10.200 | 187 | ||||||
| 2026-05-15 | 13F | Brevan Howard Capital Management LP | 19.530 | 359 | ||||||
| 2026-05-13 | 13F | Hudson Bay Capital Management LP | 88.867 | 1.632 | ||||||
| 2026-05-08 | 13F | Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 49.423 | 908 | ||||||
| 2026-05-06 | 13F | Jennison Associates Llc | 152.974 | 2.810 | ||||||
| 2026-05-13 | 13F/A | Jpmorgan Chase & Co | 41.004 | 75,69 | 681 | 146,74 | ||||
| 2026-02-17 | 13F | Two Sigma Advisers, Lp | 32.500 | 385 | ||||||
| 2026-05-15 | 13F | Exome Asset Management LLC | 153.191 | 2.814 | ||||||
| 2026-05-15 | 13F | Bank Of America Corp /de/ | 29.277 | 425,34 | 538 | 713,64 | ||||
| 2026-05-14 | 13F | Marshall Wace, Llp | 200.780 | 819,91 | 3.688 | 1.329,46 | ||||
| 2026-05-13 | 13F | BlackRock, Inc. | 115.725 | 5,95 | 2.126 | 64,09 | ||||
| 2026-05-15 | 13F | Verdad Advisers, LP | 12.748 | 234 | ||||||
| 2026-05-15 | 13F/A | Vanguard Capital Management Llc | 801.395 | 14.722 | ||||||
| 2026-05-15 | 13F | Opaleye Management Inc. | 1.312.615 | 11,40 | 24.113 | 72,55 | ||||
| 2026-05-15 | 13F | Goldman Sachs Group Inc | 228.475 | 805,03 | 4.197 | 1.303,68 | ||||
| 2026-05-15 | 13F | Millennium Management Llc | 323.553 | 422,85 | 5.944 | 710,78 | ||||
| 2026-05-11 | 13F | Caitong International Asset Management Co., Ltd | 4 | 0 | ||||||
| 2026-05-14 | 13F | Algert Global Llc | 13.806 | 0 | ||||||
| 2026-05-15 | 13F | Royal Bank Of Canada | 51 | 155,00 | 1 | |||||
| 2026-05-15 | 13F | Balyasny Asset Management Llc | 1.510.033 | 1.251,68 | 27.739 | 1.995,09 | ||||
| 2026-05-08 | 13F | Vanguard Global Advisers, LLC | 3.469 | 64 | ||||||
| 2026-05-15 | 13F | Tang Capital Management Llc | 1.160.000 | 32,97 | 21.309 | 105,96 | ||||
| 2026-05-14 | 13F | Lighthouse Investment Partners, LLC | 25.000 | 459 |
